Bayer AG (#BAYN) Stock Price, Live Chart & Analysis | Trade #BAYN
Bayer AG is a German pharmaceutical company headquartered in Leverkusen, Germany. It is one of the largest pharmaceutical companies in the world. Bayer produces some of the top-selling pharmaceutical products, such as Kogenate, Xarelto, Betaseron and others. The company also produces consumer healthcare products, biotechnology products, seeds and chemicals (fungicides, herbicides and insecticides) for the agricultural industry.
Apart from the always-relevant dive into the financial performance of the company, traders and investors should look into the pharmaceutical industry, its trends and prospects. For instance, during the times of epidemics, companies with the fastest and most innovative approach to the vaccine and medication development will see their stocks grow rapidly. Major competitors of Bayer, such as AstraZeneca, Johnson & Johnson and Pfizer were all involved in the COVID-19 vaccine development and production which contributed to their stocks' price growth.
One should also look into the history of the company's acquisition and its overall market share. Bayer has a long history of successful acquisitions sometimes reaching two or three per year. For instance, in 2021, it acquired Noria Therapeutics Inc., PSMA Therapeutics Inc., and Vividion Therapeutics. One of the biggest acquisitions was that of seeds company Monsanto completed in 2018 for $66 billion. This was a major bullish factor for the BAYN price.
Some of the negative factors affecting the BAYN rate are lawsuits and scandals surrounding the company. In 2018, Bayer was ordered to pay $289 million to a person who claimed that his Non-Hodgkin's lymphoma was caused by Monsanto's herbicide Roundup. Following the verdict, the BAYN stock price decreased by around 14%. The company has also been involved in several other lawsuits regarding its pharmaceutical products' side effects. Traders and investors should follow all such litigations because the BAYN price is heavily dependent on them.
Risk warning: Trading in FX and CFDs entails high risk of losing capital.
Are you interested in buying Bayer AG (#BAYN)? It’s easy!
SellBuyActive SellActive Buy
| Sell | 27.89 |
| Buy | 27.9 |
| Sentiment | 100% ▾ |
| 1-day change | 0.72(2.65%) |
Earn from the fluctuations of prices and boost your income with LiteFinance!
#BAYN (#BAYN) shares’ cost is $27.9 for today. The highest rate of shares #BAYN (#BAYN) for today is $28.0700, the lowest price is $27.8000. The opening price was $27.86.
A real-time chart for #BAYN (#BAYN) shares quote is provided below.
Price chart of #BAYN in real time mode
Available in trading accounts:
- ECN
- CLASSIC
Prev. Close27.87
Day's Range27.8000 - 28.0700
Opening27.86
52 wk Range24.96-51.32
Volume2,217,316
Shares Outstanding982,424,082
Average Volume2,991,356
Market Cap27.38B
1-Year Return-45.21%
EPS-1.29
Beta0.923
Revenue47.11B
P/E Ratio-21.63
Dividends0.11(0.39%)
Next Earnings Date2024-11-05
Spread0
Swap Long-6
Contract size1
Swap Short2.5
Stop&Limit Level0
Interesting facts about the #BAYN (Bayer AG)
Bayer AG isn’t only known for its endeavors in the pharmaceutical industry. The company has also done important work in the agricultural sector. For over 150 years, Bayer has led the way in crop science, developing cutting-edge digital farming methods, crop protection solutions, genetically engineered crop seeds, as well as research and development innovations. Given the uncertainty surrounding climate change and fossil fuels, Bayer’s emphasis on sustainable farming singles them out as a particularly important player in the crop science scene.
The company’s contribution to consumer health should not go without mention. Bayer owns more than 170 consumer health brands, demonstrating their active interest in "Health for All." Healthcare businesses tend to perform well on the market, and with its emphasis on sustainability, Bayer might just rise in value.
Bayer went public in 1953. It is traded under the stock ticker #BAYN on the German XETRA platform. It’s also listed on German stock exchanges, which include Berlin, Frankfurt, Dusseldorf, Munich, Hannover, Stuttgart and Hamburg. Since September 27, 2007, it has also traded beneath an OTC Level l ADR Program using the ticker #BAYRY. In March 2015, its stock price reached an all-time high of €143.53 but has since declined by more than 50%. Bayer equities remain perhaps the most affordable large-cap pharmaceutical stocks available on the market today, even despite the price volatility seen over the recent years. The share price is relatively inexpensive.
Given the company’s high market cap and share turnover, Bayer is also included in a large number of equity indices, including FTSE Euro 100 and Euro STOXX 50 in the Eurozone, CDAX, DAX and DivDAX in Germany, and FTSE Eurotop 100, FTSE Eurofirst 100, FTSE EuroFirst 300, Euro STOXX and S&P Europe 350 in Europe. Inclusion in these indices confirm the company’s reliability.
Follow us in social networks!
Live Chat
Leave a feedback